Yue Dong

Title: Innovations of Yue Dong in Recombinant Human Endostatin

Introduction

Yue Dong is an accomplished inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of modified recombinant human endostatin. His innovative work has the potential to impact anti-tumor therapies significantly.

Latest Patents

Yue Dong holds a patent for a modified recombinant human endostatin, which is characterized by the structure CHO—(CHCHO)—CHCHCH—NH-Endostar. The average molecular weight of this compound ranges from 20-40 kD. This modified endostatin enhances stability in vivo, improves blood drug concentration, and prolongs half-life. It also markedly increases the activity of inhibiting endothelial cell proliferation, thereby reducing drug dosage and decreasing administration frequency. The patent further outlines its application in preparing anti-tumor pharmaceutical compositions.

Career Highlights

Throughout his career, Yue Dong has worked with notable companies in the pharmaceutical sector. He has been associated with Jiangsu Simcere Pharmaceutical R&D Co., Ltd and Shandong Xiansheng Maidejin Biological Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in drug development and biotechnology.

Collaborations

Yue Dong has collaborated with several professionals in his field, including Xiangdong Gao and Wenbing Yao. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Yue Dong's contributions to the field of biotechnology, particularly through his patent on modified recombinant human endostatin, showcase his innovative spirit and dedication to advancing medical science. His work holds promise for improving anti-tumor therapies and enhancing patient care.